In the BioHarmony Drug Report Database
Cetrorelix
Cetrotide (cetrorelix) is a protein pharmaceutical. Cetrorelix was first approved as Cetrotide on 1999-04-12. It is used to treat ovarian hyperstimulation syndrome in the USA. It has been approved in Europe to treat ovulation and ovulation induction. The pharmaceutical is active against gonadotropin-releasing hormone receptor.
Trade Name
|
Cetrotide |
|---|---|
Common Name
|
cetrorelix |
ChEMBL ID
|
CHEMBL1200490 |
Indication
|
ovarian hyperstimulation syndrome, ovulation, ovulation induction |
Drug Class
|
Hormone-release inhibiting peptides |
Image (chem structure or protein)